
Melissa M Hudson MD
Director of Cancer Survivorship Division, Co-Leader of Cancer Control & Survivorship Program, The Charles E. Williams Endowed Chair of Oncology-Cancer Survivorship, St. Jude Children's Research Hospital.
Join to view full profile
262 Danny Thomas PlMemphis, TN 38105
Phone+1 901-595-3006
Fax+1 901-595-3842
Dr. Hudson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 1986 - 1989
University of Texas Health Science Center at HoustonResidency, Pediatrics, 1983 - 1986
McGovern Medical School at UTHealthClass of 1983
Texas A&M UniversityBS, Summa Cum Laude, 1979
Certifications & Licensure
TN State Medical License 1989 - 2027
TX State Medical License 1983 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Association of American Physicians, 2017
- Fellow American Society of Clinical Oncology, 2017
- Houston Distinguished Alumna University of Texas Medical School, 2011
Clinical Trials
- Protocol For Collecting Data On Patients With Childhood Cancer Start of enrollment: 2000 Jun 08
- Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer Start of enrollment: 2007 Sep 13
- Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Publications & Presentations
PubMed
- Risk-based long-term follow-up care for children with acute lymphoblastic leukemia treated on Chinese Children's Cancer Group ALL-2015 protocol.Jiaoyang Cai, Yinting Cheung, Chinghon Pui, Melissa M Hudson
Chinese Medical Journal. 2026-08-20 - Prognostic Models for Optimal and Improved Health-Related Quality-of-Life Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.Madeline R Horan, Fiona Schulte, Yan Chen, Yutaka Yasui, Wendy Leisenring
JCO Clinical Cancer Informatics. 2026-08-19 - Body mass index during and early after therapy for pediatric acute lymphoblastic leukemia is associated with obesity in survivors.Kunanya Suwannaying, Grace C Zhou, Nawachai Lertvivatpong, Achal Neupane, Kateryna Petrykey
Haematologica. 2026-08-01
Journal Articles
- Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE)Kim E Nichols, Melissa M Hudson, Chimene A Kesserwan, Matthew J Ehrhardt, James R Downing, Clinical Cancer Research
- Association of Bacteremic Sepsis with Long-Term Neurocognitive Dysfunction in Pediatric Patients with Acute Lymphoblastic LeukemiaHiroto Inaba, Joshua Wolf, Kevin R Krull, Melissa M Hudson, JAMA
- Serum ALT Elevations in Survivors of Childhood Cancer. A Report from the St. Jude Lifetime Cohort StudyMatthew J Krasin, Sima Jeha, Daniel M Green, Melissa M Hudson, Wayne L Furman, Michael W Bishop, Hepatology
Books/Book Chapters
Abstracts/Posters
- Associations between Persistent Inflammation and Oxidative Stress with Neurocognitive Impairment in Long-Term Hodgkin Lymphoma Survivors and Community ControlsMelissa M. Hudson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Impact of Competing Treatment Scenarios on Lifetime Disease Burden and Quality Adjusted Life Expectancy (QALE) Among Survivors of High-Risk Childhood Hodgkin Lymphoma ...Melissa M. Hudson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adult...Melissa M. Hudson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Artificial Intelligence Learns to Make Sense of Childhood Cancer Survivors’ Health Care NeedsMarch 26th, 2026
Conquer Cancer Announces 2025 Genitourinary Cancers Symposium Merit AwardsJanuary 30th, 2025- Healthy Lifestyle Mitigates Impact of Childhood CancerApril 10th, 2023
Grant Support
- The St. Jude Lifetime Cohort StudyST. JUDE CHILDREN'S RESEARCH HOSPITAL2025–2030
- Early Identification of Childhood Cancer Survivors at High Risk for Late Onset Cardiomyopathy: An Artificial Intelligence Approach utilizing ElectrocardiographyWAKE FOREST UNIVERSITY HEALTH SCIENCES2022–2026
- The St. Jude Lifetime CohortST. JUDE CHILDREN'S RESEARCH HOSPITAL2015–2025
- Evaluation Of Cardiovascular Outcomes Among Childhood Cancer SurvivorsNational Institute Of Nursing Research2009–2011
- Hepatitis C In Childhood Cancer SurvivorsNational Cancer Institute2000–2003
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









